NCT01745952
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- University Hospitals Leuven, department of Neurology Leuven, Belgium
Clinical trial condition
Epilepsies, Partial
Explore clinical trials studying Epilepsies, Partial. Study availability and eligibility vary by location and protocol.
49 public trials
3 recruiting studies
Epilepsies, Partial trial results
NCT00512317
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +6 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Barrow Neurological Institute Phoenix, Arizona, United States
- Arkansas Epilepsy Program Little Rock, Arkansas, United States
- University of Southern California Adult Comprehensive Epilepsy Center Los Angeles, California, United States
NCT03446664
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +4 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Denver Colorado Denver, Colorado, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Rush University Chicago, Illinois, United States
Completed
Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy
NCT03200769
- Conditions
- Apnea, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- CHRU de Lille - Rue Emile LAINE - Hopitâl Roger Salengro Rez de Chaussée - Neurophysiologie Clinique Lille, France
NCT00351611
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- Neurology Center, P.C. Mobile, Alabama, United States
- Premier Medical Group Mobile, Alabama, United States
- Neurology Clinic, PC Northport, Alabama, United States
- North River Ophthalmology Tuscaloosa, Alabama, United States
NCT00437281
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Jonesboro, Arkansas, United States
NCT00620555
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
- Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
- Pfizer Investigational Site Kobe, Hyōgo, Japan
- Pfizer Investigational Site Suma-Ku,Kobe, Hyōgo, Japan
NCT01441401
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
Not specified
NCT00603473
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
- Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
- Pfizer Investigational Site Sapporo, Hokkaido, Japan
- Pfizer Investigational Site Kobe, Hyōgo, Japan
Completed
Drug Use Investigation Of Gabapentin
NCT00567268
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
Not specified